Without clear leadership, the FDA is falling short (Seattle Times)
The Food and Drug Administration has been without a permanent leader for more than two-thirds of President Bush's tenure in office, and...

Cyberonics Announces 1,100th Patient Treated With VNS Therapy(tm) for Treatment-Resistant Depression (TRD) Since FDA (PR Newswire via Yahoo! Finance)
Cyberonics, Inc. today announced that the 1,100th patient in the U.S. has been treated with Vagus Nerve Stimulation Therapy for treatment-resistant depression since FDA approval in July 2005.